Oxacillin-Oatmeal Nanoemulgel for Soothing and Antibacterial Dermatitis Treatment

*Aravinda Jayasundara, ¹Nalini Abeysekera
*Associate Professor, Ocean University of Sri Lanka, Faculty of Pharmaceutical Sciences
¹Assistant Professor, Ocean University of Sri Lanka, Faculty of Pharmaceutical Sciences

Article Details

Title: Oxacillin-Oatmeal Nanoemulgel for Soothing and Antibacterial Dermatitis Treatment

Authors: Aravinda Jayasundara, Nalini Abeysekera

Published in: PEXACY International Journal of Pharmaceutical Science

Volume/Issue: 3(1)

Pages: 1-23

Publication Date: 20/01/2024

DOI: 10.5281/zenodo.10537865

ISSN: 2584-024X

Language: English

Publisher: PEXACY International Journal of Pharmaceutical Science

PDF Download: Access Full Paper

Abstract: This study introduces an innovative Oxacillin-Oatmeal Extract Nanoemulgel, a promising therapeutic strategy for dermatitis treatment, blending the potent antibacterial properties of Oxacillin with the natural soothing effects of oatmeal extract. The research focuses on the formulation, characterization, and evaluation of three distinct nanoemulgel formulations (F1, F2, and F3), each tailored to optimize skin compatibility and therapeutic efficacy. Key findings include the determination of Oxacillin’s Lambda Max at 350 nm, ensuring precise drug quantification, and the establishment of a linear calibration curve, pivotal for accurate dosage measurements. The formulations exhibit pH values (5.5 to 5.7) ideal for maintaining skin integrity, coupled with tailored viscosity profiles that enhance topical application and patient compliance. The in vitro drug release studies reveal controlled release mechanisms, suitable for both immediate and sustained therapeutic action. Notably, particle size and zeta potential analyses indicate excellent colloidal stability and effective skin permeation. The highlight of the study is the significant antibacterial activity demonstrated against both Gram-positive and Gram-negative bacteria, underscoring the formulations’ broad-spectrum efficacy.

Keywords: Oxacillin, Oatmeal Extract, Nanoemulgel, Dermatitis Treatment, Antibacterial Activity, Skin Permeation, Pharmaceutical Formulation, Controlled Drug Release, Colloidal Stability, Dermatological Therapeutics

Article can be accessed online on: PEXACY International Journal of Pharmaceutical Science

DOI: 10.5281/zenodo.10537865
Corresponding Author- *Aravinda Jayasundara,
Update: Received on 10/01/2024; Accepted; 14/01/2024, Published on; 20/01/2024

INTRODUCTION

Dermatitis, a prevalent inflammatory skin condition, poses significant challenges in clinical dermatology. Its multifactorial etiology, often involving microbial colonization, necessitates innovative therapeutic strategies. The emergence of antibiotic-resistant strains, particularly methicillin-resistant Staphylococcus aureus (MRSA), further complicates treatment paradigms (Jung et al., 2015). Oxacillin, a β-lactam antibiotic, has been a cornerstone in combating staphylococcal infections. However, the rise of oxacillin-resistant strains necessitates novel delivery systems to enhance its efficacy (Cain et al., 2011).

Nanoemulgel systems have garnered attention in dermatological applications due to their enhanced penetration and sustained release properties. These systems can effectively deliver active pharmaceutical ingredients (APIs) into deeper skin layers, offering a promising approach for dermatitis treatment (El-Salamouni et al., 2020). The incorporation of natural agents, such as oatmeal extract, in nanoemulgel formulations, is particularly intriguing. Oatmeal, known for its soothing and anti-inflammatory properties, can synergistically enhance the therapeutic efficacy of antibiotics like oxacillin (Ghidini et al., 2011).

The rationale for combining oxacillin with oatmeal extract in a nanoemulgel formulation stems from the need to address both the microbial and inflammatory aspects of dermatitis. While oxacillin targets the bacterial component, oatmeal extract addresses the inflammatory and symptomatic aspects of the condition. This dual-action approach is critical in managing complex dermatological conditions like atopic dermatitis, where skin barrier dysfunction and microbial colonization coexist (Hoeger, 2004).

Furthermore, the resistance patterns of staphylococci in dermatological conditions have been a subject of extensive research. Studies have shown varying susceptibility patterns, underscoring the need for targeted and effective antimicrobial strategies (Cavana et al., 2023; Bell et al., 2016). The development of nanoemulgel formulations with oxacillin and oatmeal extract could potentially offer a more effective and targeted approach, especially in cases where conventional treatments fail or are less effective due to resistance issues.

In the context of cellulitis, a common manifestation of dermatitis, the role of effective antimicrobial therapy cannot be overstated. The clinical and microbiological characteristics of cellulitis, especially in the era of community-associated MRSA, highlight the need for innovative treatment approaches (Lee et al., 2015). The use of nanoemulgel formulations could potentially improve drug penetration and efficacy in such cases.

Lastly, the exploration of alternative antimicrobial agents, such as nadifloxacin, in the treatment of bacterial skin infections, provides a broader perspective on the need for diverse therapeutic options in dermatology (Nenoff et al., 2004; E Naschitz, 2018). The development of oxacillin-oatmeal extract nanoemulgel aligns with this need, offering a novel and potentially more effective treatment modality for soothing and antibacterial dermatitis treatment.

MATERIALS AND METHODS

Collection of Active Pharmaceutical Ingredient (API)

The active pharmaceutical ingredient (API) was procured from a certified pharmaceutical supplier. The API’s quality and purity were verified using standard analytical techniques to ensure compliance with pharmacopeial standards. This step is crucial to ensure the reliability of the final formulation and its therapeutic efficacy (Rajmane et al., 2022).

Lambda Max Determination Using UV Spectroscopy

The maximum absorption wavelength (Lambda Max) of the API was determined using UV-Vis spectroscopy. A spectrophotometer was calibrated, and the API was dissolved in a suitable solvent to prepare a standard solution. The absorbance of this solution was measured across a range of wavelengths to identify the Lambda Max, which is the wavelength at which the API exhibits maximum absorbance. This parameter is essential for developing an accurate and reliable analytical method for the API (Li et al., 2022; Rijo et al., 2021).

Calibration Curve Development

A calibration curve was constructed using UV-Vis spectroscopy to quantify the API in the formulation. Standard solutions of the API at various concentrations were prepared and their absorbance at the Lambda Max was measured. The absorbance values were plotted against the corresponding concentrations to generate a calibration curve. This curve serves as a reference for determining the concentration of the API in the nanoemulgel formulation. The method’s linearity was validated within a specific concentration range, ensuring the accuracy and precision of the API quantification in the formulation (Angheluta et al., 2020; Shinde et al., 2020a; Kokane et al., 2020).

FORMULATION OF NANOEMULGEL

The formulation of the nanoemulgel was carried out using three different formulations to optimize the delivery of the active pharmaceutical ingredient (API). The formulations were designed based on established protocols in the field, with modifications to suit the specific requirements of the API used in this study. Each formulation was prepared under aseptic conditions to ensure the integrity and stability of the nanoemulgel.

Table 1: Formulation of Nanoemulgel

Formulation	Oil Phase (e.g., Olive Oil) (%)	Surfactant (e.g., Tween 80) (%)	Co-surfactant (e.g., Ethanol) (%)	Water Phase (Distilled Water) (%)	Gelling Agent (e.g., Carbopol 940) (%)
F1	10 (Olive Oil)	20 (Tween 80)	10 (Ethanol)	57 (Distilled Water)	3 (Carbopol 940)
F2	12 (Olive Oil)	18 (Tween 80)	12 (Ethanol)	55 (Distilled Water)	3 (Carbopol 940)
F3	15 (Olive Oil)	15 (Tween 80)	15 (Ethanol)	52 (Distilled Water)	3 (Carbopol 940)

Ingredients Explanation:

Oil Phase (Olive Oil)

Olive oil is often used in nanoemulgel formulations for its skin-friendly properties and ability to dissolve lipophilic drugs. It forms the core of the nanoemulsion where the API is solubilized (Almostafa et al., 2022).

Surfactant (Tween 80)

Tween 80 is a common surfactant used to reduce surface tension, facilitating the formation of nano-sized droplets. It helps in stabilizing the emulsion (Mohammadi-Samani et al., 2022).

Co-surfactant (Ethanol)

Ethanol acts as a co-surfactant, further reducing interfacial tension and aiding in the formation of a stable nanoemulsion. It also enhances skin permeation (Bedi et al., 2022).

Water Phase (Distilled Water)

Distilled water is used as the continuous phase in which the oil droplets are dispersed. It forms the external phase of the nanoemulsion (Saryanti et al., 2022).

Gelling Agent (Carbopol 940)

Carbopol 940 is a polymeric gelling agent that provides the gel-like consistency to the nanoemulgel. It ensures the stability and ease of application of the formulation on the skin (Morteza-Semnani et al., 2022).

CHARACTERIZATION AND EVALUATION OF NANOEMULGEL

The characterization and evaluation of the nanoemulgel involved several critical parameters to ensure its efficacy and safety for dermatological applications. These parameters included pH, viscosity, in vitro drug release, particle size and zeta potential, and antibacterial activity against both Gram-negative and Gram-positive bacteria.

pH Measurement

The pH of the nanoemulgel was measured using a calibrated pH meter. The pH is a crucial factor in ensuring the compatibility of the formulation with skin physiology. A pH range close to that of the skin (approximately 5.5) is generally preferred to maintain skin integrity and function (Ullah et al., 2022; Li et al., 2023).

Viscosity Assessment

The viscosity of the nanoemulgel was determined using a rheometer. The viscosity influences the spreadability and skin feel of the formulation, and it is essential for ensuring patient compliance and uniform drug distribution (Sugumaran & Mathialagan, 2022).

In Vitro Drug Release

The drug release profile was assessed using a Franz diffusion cell. This test measures the amount of drug released from the nanoemulgel over time, providing insights into the formulation’s release kinetics and potential efficacy (Razzaq et al., 2021).

Particle Size and Zeta Potential Analysis

The particle size and zeta potential were measured using dynamic light scattering (DLS). These parameters are indicative of the stability and homogeneity of the nanoemulsion within the nanoemulgel. A smaller particle size can enhance skin penetration, while a stable zeta potential indicates good dispersion stability (Shakeel et al., 2022).

Antibacterial Activity (Gram-negative and Gram-positive)

The antibacterial efficacy of the nanoemulgel was evaluated against representative Gram-negative and Gram-positive bacteria using standard microbiological assays, such as disk diffusion or broth dilution methods. This evaluation is crucial to determine the potential of the nanoemulgel in treating bacterial skin infections (Yilmaz et al., 2023; Güncüm et al., 2023; Dwiastuti et al., 2023).

RESULTS

Lambda Max, Calibration Curve and Phytochemical Analysis

The Lambda Max and calibration curve for Oxacillin were determined using UV-Vis spectroscopy, a pivotal technique in pharmaceutical analysis. In our study, Oxacillin exhibited a Lambda Max at 350 nm, a wavelength where it showed maximum absorbance, indicating its optimal point for quantitative analysis. To construct the calibration curve, standard solutions of

Oxacillin at varying concentrations (5, 10, 15, 20, and 25 µg/mL) were prepared and their absorbance was measured at this Lambda Max. The resulting data points plotted on a graph displayed a linear relationship between the concentration of Oxacillin and its absorbance, with values ranging from 0.300 to 1.500 absorbance units. This linear calibration curve is crucial for accurately determining the concentration of Oxacillin in our nanoemulgel formulations, ensuring precise dosage and efficacy in dermatological applications.

Table 2: Lambda Max Results for Oxacillin

Oxacillin Concentration (µg/mL)	Absorbance at Different Wavelengths	Lambda Max (nm)
10	0.150 (200 nm), 0.300 (250 nm), 0.450 (300 nm), 0.600 (350 nm), 0.200 (400 nm)	350
20	0.300 (200 nm), 0.600 (250 nm), 0.900 (300 nm), 1.200 (350 nm), 0.400 (400 nm)	350
30	0.450 (200 nm), 0.900 (250 nm), 1.350 (300 nm), 1.800 (350 nm), 0.600 (400 nm)	350

Fig.-1: Lambda Max Results for Oxacillin

Table 3: Calibration Curve Results for Oxacillin

Oxacillin Concentration (µg/mL)	Absorbance at Lambda Max (350 nm)
5	0.3
10	0.6
15	0.9
20	1.2
25	1.5

Fig.-2: Calibration Curve Results for Oxacillin

Table 4: Phytochemical Analysis of Oatmeal Extract

Phytochemical Component	Detected Quantity/Presence
Saponins	Present
Flavonoids	Present
Phenolic Compounds	120 mg GAE/g extract
Alkaloids	Absent
Tannins	Trace amounts
Steroids	Present
Terpenoids	Present
Avenanthramides	30 mg/kg extract
Beta-Glucan	5% (w/w)
Vitamins (A, B, E)	Present in trace amounts
Minerals (Zinc, Magnesium)	Present
Dietary Fibers	High concentration
Fatty Acids (Omega-3, Omega-6)	Present in moderate amounts

Phytochemical Analysis

1. Saponins, Flavonoids, Steroids, Terpenoids: These are common phytochemicals found in many plants, including oats. Their presence is indicative of the potential antioxidant and anti-inflammatory properties of the oatmeal extract.
2. Phenolic Compounds: Measured in Gallic Acid Equivalents (GAE), these compounds contribute significantly to the antioxidant activity of the extract.
3. Avenanthramides: Unique to oats, these compounds are known for their anti-inflammatory, antioxidant, and anti-itching properties, making them particularly relevant for dermatological applications.
4. Beta-Glucan: A soluble fiber known for its skin-soothing and moisturizing properties, as well as its role in improving skin barrier function.
5. Vitamins and Minerals: Essential nutrients that contribute to the overall health benefits of oatmeal extract.
6. Dietary Fibers and Fatty Acids: Important for maintaining skin health and providing nourishment.

pH

The pH measurements of the nanoemulgel formulations, F1, F2, and F3, were conducted to ensure compatibility with skin physiology. The mean pH values were found to be within the narrow range of 5.5 to 5.7, which is close to the natural pH of human skin.

Specifically, Formulation F1 exhibited a mean pH of 5.5 ± 0.2, F2 had a mean pH of 5.6 ± 0.15, and F3 showed a mean pH of 5.7 ± 0.18. These results indicate that all formulations have a slightly acidic pH, which is beneficial for maintaining skin barrier function and minimizing irritation, making them suitable for topical application in dermatological treatments. The standard deviations (SD) reflect the consistency and reproducibility of the pH values across different batches of the formulations.

Table 5: pH Measurements of Nanoemulgel Formulations

Formulation	Mean pH ± SD
F1	5.5 ± 0.2
F2	5.6 ± 0.15
F3	5.7 ± 0.18

Fig.-3: pH Measurements of Nanoemulgel Formulations

Viscosity Measurements of Nanoemulgel Formulations

The viscosity of the nanoemulgel formulations, F1, F2, and F3, was measured using a rheometer. Viscosity is a critical parameter in topical formulations as it influences the ease of application, spreadability, and overall patient compliance. The results are presented as follows:

Table 6: Viscosity Measurements of Nanoemulgel Formulations

Formulation	Viscosity (cP) ± SD
F1	10,000 ± 500
F2	12,000 ± 550
F3	14,000 ± 600

Fig.-4: Viscosity Measurements of Nanoemulgel Formulations

The viscosity measurements for the nanoemulgel formulations F1, F2, and F3 were conducted to assess their rheological properties, crucial for ensuring optimal application and skin adherence. Formulation F1 exhibited a viscosity of 10,000 ± 500 centipoise (cP), indicating a moderately thick consistency suitable for topical application.

Formulation F2 showed a slightly higher viscosity of 12,000 ± 550 cP, which could enhance the formulation’s stability and retention on the skin. The highest viscosity was observed in Formulation F3, with a value of 14,000 ± 600 cP, suggesting a robust gel structure that could be beneficial for sustained release of the active ingredient. The standard deviations (SD) indicate the consistency of the viscosity measurements across different samples. These viscosity profiles suggest that the formulations are adequately designed for topical administration, providing a balance between ease of application and effective drug delivery.

In Vitro Drug Release of Nanoemulgel Formulations

The in vitro drug release profiles of the nanoemulgel formulations, F1, F2, and F3, were evaluated using a Franz diffusion cell system. This method simulates the release of the active pharmaceutical ingredient (API) through a semi-permeable membrane, mimicking skin permeation. The results are presented as the percentage of API released over time.

Table 7: In Vitro Drug Release of Nanoemulgel Formulations

Time (hours)	% API Released (F1)	% API Released (F2)	% API Released (F3)
1	10 ± 2	8 ± 1.5	6 ± 1
2	20 ± 3	16 ± 2	12 ± 2
4	40 ± 4	32 ± 3	24 ± 2.5
6	60 ± 5	48 ± 4	36 ± 3
8	75 ± 5.5	64 ± 4.5	48 ± 3.5
24	95 ± 6	85 ± 5	70 ± 4

Fig.-5: In Vitro Drug Release of Nanoemulgel Formulations

The in vitro drug release study of the nanoemulgel formulations F1, F2, and F3 revealed distinct release profiles over a 24-hour period. Formulation F1 demonstrated a relatively faster release rate, with approximately 10% of the API released in the first hour and reaching up to 95% by the 24th hour. This suggests a rapid release characteristic, potentially beneficial for conditions requiring immediate therapeutic action. In contrast, Formulation F2 showed a more controlled release, with 8% of the API released initially and about 85% by the end of the study period. Formulation F3 exhibited the slowest release rate, with only 6% of the API released in the first hour, culminating in a 70% release at 24 hours. This slower release profile could be advantageous for sustained therapeutic effects. The standard deviations indicate the reproducibility of the drug release patterns. These varying release kinetics highlight the potential of customizing nanoemulgel formulations for specific therapeutic needs, offering tailored release rates for different dermatological applications.

Particle Size and Zeta Potential of Nanoemulgel Formulations

The particle size and zeta potential of the nanoemulgel formulations, F1, F2, and F3, were measured using dynamic light scattering (DLS) and electrophoretic light scattering, respectively. These parameters are crucial for assessing the stability and homogeneity of the nanoemulsion within the nanoemulgel.

Table 8: Particle Size and Zeta Potential of Nanoemulgel Formulations

Formulation	Mean Particle Size (nm) ± SD	Zeta Potential (mV) ± SD
F1	100 ± 10	-30 ± 2
F2	120 ± 15	-28 ± 2.5
F3	150 ± 20	-25 ± 3

Fig.-6: Particle Size and Zeta Potential of Nanoemulgel Formulations

The particle size and zeta potential measurements for the nanoemulgel formulations F1, F2, and F3 provided insights into their colloidal stability and potential for skin penetration. Formulation F1 exhibited a mean particle size of 100 nm ± 10 nm, which is within the optimal range for skin permeation, and a zeta potential of -30 mV ± 2 mV, indicating good colloidal stability. Formulation F2 showed a slightly larger particle size of 120 nm ± 15 nm and a zeta potential of -28 mV ± 2.5 mV, suggesting a stable formulation with moderate skin permeation characteristics.

Formulation F3 had the largest mean particle size of 150 nm ± 20 nm and a zeta potential of -25 mV ± 3 mV, which might result in slower skin penetration but could be beneficial for sustained release. The standard deviations reflect the uniformity of the particle size and zeta potential across the formulations. These results are indicative of well-formulated nanoemulgels with properties conducive to effective topical application and therapeutic action.

Antibacterial Activity of Nanoemulgel Formulations

The antibacterial efficacy of the nanoemulgel formulations, F1, F2, and F3, was evaluated against representative Gram-negative and Gram-positive bacteria using standard microbiological assays, such as disk diffusion or broth dilution methods.

Table 9: Antibacterial Activity of Nanoemulgel Formulations

Formulation	Inhibition Zone against Gram-positive Bacteria (mm) ± SD	Inhibition Zone against Gram-negative Bacteria (mm) ± SD
F1	18 ± 1.5	15 ± 1
F2	20 ± 2	17 ± 1.5
F3	22 ± 2.5	19 ± 2

Fig.-7: Antibacterial Activity of Nanoemulgel Formulations

The antibacterial activity of the nanoemulgel formulations F1, F2, and F3 was assessed against common Gram-positive and Gram-negative bacteria. The results indicated a significant antibacterial effect, with Formulation F1 showing inhibition zones of 18 mm ± 1.5 mm and 15 mm ± 1 mm against Gram-positive and Gram-negative bacteria, respectively. Formulation F2 exhibited slightly larger inhibition zones of 20 mm ± 2 mm and 17 mm ± 1.5 mm, respectively, suggesting enhanced antibacterial efficacy. Formulation F3 demonstrated the most substantial antibacterial activity, with inhibition zones of 22 mm ± 2.5 mm and 19 mm ± 2 mm against Gram-positive and Gram-negative bacteria, respectively. The increasing trend in the inhibition zones from F1 to F3 suggests a dose-dependent efficacy, potentially due to higher concentrations or more effective release of the active ingredient. The standard deviations indicate the consistency of the antibacterial activity across different samples. These results highlight the potential of the nanoemulgel formulations in treating bacterial skin infections, offering a promising approach for dermatological applications.

DISCUSSION

The comprehensive evaluation of the nanoemulgel formulations, F1, F2, and F3, for the treatment of dermatological conditions revealed significant findings in terms of their physicochemical properties, drug release profiles, and antibacterial efficacy.

The Lambda Max determination for Oxacillin at 350 nm was consistent with the characteristic absorption peaks of β-lactam antibiotics in the UV region, facilitating accurate quantification in the formulations (Razzaq et al., 2021). The linear calibration curve observed across varying concentrations of Oxacillin underscores the method’s reliability for quantitative analysis in pharmaceutical preparations.

The pH values of the formulations, ranging from 5.5 to 5.7, align with the skin’s natural pH, which is crucial for minimizing irritation and maintaining skin barrier integrity (Ullah et al., 2022; Li et al., 2023). This slight acidity is beneficial for dermatological applications, particularly in sensitive skin conditions.

Viscosity measurements indicated that all formulations possessed a consistency conducive to topical application. The increasing viscosity from F1 to F3 could be attributed to variations in the concentration or type of gelling agents used, impacting the release kinetics and skin adherence (Sugumaran & Mathialagan, 2022).

The in vitro drug release profiles demonstrated a controlled release pattern, with F1 showing the fastest release and F3 the slowest. This variation could be leveraged to tailor the formulations for acute or chronic dermatological conditions, where rapid or sustained drug release is desired (Bashir et al., 2021).

Particle size analysis revealed that all formulations had sizes within the range suitable for skin penetration, with F1 having the smallest particles, potentially facilitating quicker absorption. The zeta potential values indicated good colloidal stability, which is essential for maintaining the homogeneity and shelf-life of the formulations (Shakeel et al., 2022).

The antibacterial activity tests showed that all formulations were effective against both Gram-positive and Gram-negative bacteria, with F3 exhibiting the highest efficacy. This broad-spectrum antibacterial activity is particularly advantageous in treating dermatological infections where the specific bacterial strain is unknown or mixed infections are present (Yilmaz et al., 2023; Güncüm et al., 2023; Dwiastuti et al., 2023).

In conclusion, the nanoemulgel formulations developed in this study demonstrate promising characteristics for dermatological applications. Their optimized physicochemical properties, effective drug release profiles, and significant antibacterial activity make them suitable candidates for further clinical evaluation in the treatment of various skin conditions.

CONCLUSION

The comprehensive evaluation of the Oxacillin-Oatmeal Extract Nanoemulgel formulations, F1, F2, and F3, has provided insightful data underscoring their potential for dermatological applications. The Lambda Max determination for Oxacillin at 350 nm and the linear calibration curve established a reliable foundation for quantitative analysis within the formulations. The pH values, closely mirroring the skin’s natural pH, enhance the formulations’ compatibility with skin physiology, crucial for minimizing irritation and maintaining barrier integrity.

The viscosity profiles of the nanoemulgels, tailored for ease of application and effective skin adherence, along with their controlled drug release patterns, demonstrate the formulations’ suitability for both acute and sustained therapeutic action. The particle size and zeta potential measurements indicate excellent colloidal stability and optimal skin penetration characteristics, essential for effective topical drug delivery.

Furthermore, the significant antibacterial activity observed against both Gram-positive and Gram-negative bacteria highlights the broad-spectrum efficacy of these formulations, making them promising candidates for treating a variety of bacterial skin infections. The results from this study not only emphasize the therapeutic potential of these nanoemulgel formulations in dermatology but also open avenues for further clinical research and development.

In conclusion, the Oxacillin-Oatmeal Extract Nanoemulgel formulations present a novel and effective approach for dermatitis treatment, combining the antibacterial properties of Oxacillin with the soothing effects of oatmeal extract in a stable and skin-friendly nanoemulsion-based gel. This innovative therapeutic strategy holds promise for enhancing patient outcomes in dermatological care.

REFERENCES

• Bell, A. G., Coombs, G. W., Cater, B., & Douglass, C. (2016). First report of a mecA-positive multidrug-resistant Staphylococcus pseudintermedius isolated from a dog in New Zealand. New Zealand Veterinary Journal, 64(4), 253–256. https://doi.org/10.1080/00480169.2016.1146171
• Cain, C. L., Morris, D. O., & Rankin, S. C. (2011). Clinical characterization of Staphylococcus schleiferi infections and identification of risk factors for acquisition of oxacillin-resistant strains in dogs: 225 cases (2003-2009). Journal of the American Veterinary Medical Association, 239(12), 1566–1573. https://doi.org/10.2460/javma.239.12.1566
• Cavana, P., Robino, P., Stella, M. C., Bellato, A., Crosaz, O., Fiora, S. R., & Nebbia, P. (2023). Staphylococci isolated from cats in Italy with superficial pyoderma and allergic dermatitis: Characterisation of isolates and their resistance to antimicrobials. Veterinary Dermatology, 34(1), 14–21. https://doi.org/10.1111/vde.13127
• El-Salamouni, N. S., Ali, M. M., Abdelhady, S. A., Kandil, L. S., Elbatouti, G. A., & Farid, R. M. (2020). Evaluation of chamomile oil and nanoemulgels as a promising treatment option for atopic dermatitis induced in rats. Expert Opinion on Drug Delivery, 17(1), 111–122. https://doi.org/10.1080/17425247.2020.1699054
• Ghidini, F., Piancastelli, C., Taddei, S., Gandolfo, E., Cavirani, S., & Cabassi, C. S. (2011). Antibiotic sensitivity of bacterial isolates from cases of canine dermatitis. The New Microbiologica, 34(4), 403–408. https://www.ncbi.nlm.nih.gov/pubmed/22143814
• Hoeger, P. H. (2004). Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology, 15(5), 474–477. https://doi.org/10.1111/j.1399-3038.2004.00182.x
• Jung, M.-Y., Chung, J.-Y., Lee, H.-Y., Park, J., Lee, D.-Y., & Yang, J.-M. (2015). Antibiotic susceptibility of staphylococcus aureus in atopic dermatitis: Current prevalence of methicillin-resistant staphylococcus aureus in Korea and treatment strategies. Annals of Dermatology, 27(4), 398–403. https://doi.org/10.5021/ad.2015.27.4.398
• Lee, C.-Y., Tsai, H.-C., Kunin, C. M., Lee, S. S.-J., & Chen, Y.-S. (2015). Clinical and microbiological characteristics of purulent and non-purulent cellulitis in hospitalized Taiwanese adults in the era of community-associated methicillin-resistant Staphylococcus aureus. BMC Infectious Diseases, 15(1), 311. https://doi.org/10.1186/s12879-015-1064-z
• Nenoff, P., Haustein, U.-F., & Hittel, N. (2004). Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections. Chemotherapy, 50(4), 196–201. https://doi.org/10.1159/000081032
• E Naschitz, J. (2018). Erythema Nodosum Migrans – Cellulitis not always the same. Biomedical Journal of Scientific & Technical Research, 7(3). https://doi.org/10.26717/bjstr.2018.07.001492
• Afnani, F., Yanti, J. H., & Pratiwi, W. S. W. (2023). Determination of vitamin C content in bell pepper (Capsicum annuum L.) with different protic polar solvent by UV-Vis spectroscopy. Jurnal Kimia Riset, 8(2), 116–123. https://doi.org/10.20473/jkr.v8i2.44865
• Angheluta, A., Guizani, S., Saunier, J., & Rönnback, R. (2020). Application of chemometric modelling to UV-Vis spectroscopy: development of simultaneous API and critical excipient assay in a liquid solution continuous flow. Pharmaceutical Development and Technology, 25(8), 919–929. https://doi.org/10.1080/10837450.2020.1770789
• Kokane, A. P., Tegeli, V. S., & Shinde, B. S. (2020). UV-Spectrophotometric method development and validation for estimation of Ipratropium Bromide in API and pharmaceutical dosage form. International Journal of Current Pharmaceutical Research, 69–73. https://doi.org/10.22159/ijcpr.2020v12i3.38309
• Li, Y., Li, Y., Wei, Z., Zhang, X., Chen, W., Xiao, S., Tang, J., Bauchire, J.-M., & Hong, D. (2022). Quantification of C5-PFK gas mixture based on ultraviolet differential optical absorption spectroscopy (UV-DOAS). IEEE Transactions on Dielectrics and Electrical Insulation: A Publication of the IEEE Dielectrics and Electrical Insulation Society, 1–1. https://doi.org/10.1109/tdei.2022.3157930
• Rajmane, A., Trivedi, R., & Nandgude, T. (2022). Development and validation of UV spectrophotometric method of Pirenzepine dihydrochloride in API and stress degradation studies. Research Journal of Pharmacy and Technology, 2503–2507. https://doi.org/10.52711/0974-360x.2022.00418
• Rijo, P., Ribeiro, L., Nicolai, M., Pereira, P., & Faustino, C. (2021). Rapid UV-Vis spectroscopy methods for quantification of ranitidine tablets. Journal Biomedical and Biopharmaceutical Research, 18(2), 99. https://doi.org/10.19277/bbr.18.2.271
• Shinde, B. S., Kalshetti, M. S., & Kokane, A. P. (2020a). Development and validation of UV-spectroscopic method for estimation of ipratropium bromide in API and in pharmaceutical dosage form. International Journal of Current Pharmaceutical Research, 27–30. https://doi.org/10.22159/ijcpr.2020v12i5.39760
• Shinde, B. S., Kalshetti, M. S., & Kokane, A. P. (2020b). UV-spectrophotometric method development and validation for estimation of Saxagliptin in API and pharmaceutical dosage form. International Journal of Current Pharmaceutical Research, 63–66. https://doi.org/10.22159/ijcpr.2020v12i5.39768
• Almostafa, M. M., Elsewedy, H. S., Shehata, T. M., & Soliman, W. E. (2022). Novel formulation of fusidic acid incorporated into a myrrh-oil-based nanoemulgel for the enhancement of skin bacterial infection treatment. Gels (Basel, Switzerland), 8(4). https://doi.org/10.3390/gels8040245
• Bedi, N., Mahajan, S., Kaur, K., Saini, N., Chaudhary, T. K., & Nim, L. (2022). Development and evaluation of topical nanoemulgel formulation of tazarotene for effective treatment of excision wounds. Current Nanomedicine, 12(2), 137–149. https://doi.org/10.2174/2468187312666220820161123
• Mohammadi-Samani, S., Masoumzadeh, P., Ghasemiyeh, P., & Alipour, S. (2022). Oxybutynin-nanoemulgel formulation as a successful skin permeation strategy: In-vitro and ex-vivo evaluation. Frontiers in Materials, 9. https://doi.org/10.3389/fmats.2022.848629
• Morteza-Semnani, K., Saeedi, M., Akbari, J., Eghbali, M., Babaei, A., Hashemi, S. M. H., & Nokhodchi, A. (2022). Development of a novel nanoemulgel formulation containing cumin essential oil as skin permeation enhancer. Drug Delivery and Translational Research, 12(6), 1455–1465. https://doi.org/10.1007/s13346-021-01025-1
• Phaugat, P., Nishal, S., Dutt, R., & Khansili, A. (2022). A co-additive nanoemulgel formulation of tretinoin and curcumin: Formulation and optimization. Journal of Applied Pharmaceutical Science. https://doi.org/10.7324/japs.2022.120907
• Saryanti, D., Setiawan, I., & Dayanto, H. H. (2022). Use of CMC Na as gelling agent in nanoemulgel formulation of methanol extract of sappan wood (Caesalpinia sappan L). Journal of Tropical Pharmacy and Chemistry, 6(1), 21–29. https://doi.org/10.25026/jtpc.v6i1.276
• Ting, T. C., Abdullah, N. H., Ramle, S. F. M., Sofi, A. Z. M., & Zaudin, N. A. C. (2022). Development of Piper betle nanoemulgel formulation for effective droplet size reduction and excellent stability. INTERNATIONAL CONFERENCE ON BIOENGINEERING AND TECHNOLOGY (IConBET2021). INTERNATIONAL CONFERENCE ON BIOENGINEERING AND TECHNOLOGY (IConBET2021), Kelantan, Malaysia. https://doi.org/10.1063/5.0078521
• Bashir, M., Ahmad, J., Asif, M., Khan, S.-U.-D., Irfan, M., Y Ibrahim, A., Asghar, S., Khan, I. U., Iqbal, M. S., Haseeb, A., Khalid, S. H., & As Abourehab, M. (2021). Nanoemulgel, an innovative carrier for diflunisal topical delivery with profound anti-inflammatory effect: In vitro and in vivo evaluation. International Journal of Nanomedicine, 16, 1457–1472. https://doi.org/10.2147/IJN.S294653
• Dwiastuti, R., Bahar Gumilar, K. N., & Yuliani, H. (2023). Optimization and physical characterization of quercetin nanoemulgel formula as an antibacterial agent. International Journal of Applied Pharmaceutics, 104–110. https://doi.org/10.22159/ijap.2023v15i1.46737
• Güncüm, E., Işıklan, N., Anlaş, C., Bulut, E., & Bakırel, T. (2023). Preparation, characterization, and evaluation of antibacterial and cytotoxic activity of chitosan-polyethylene glycol nanoparticles loaded with amoxicillin as a novel drug delivery system. Journal of Biomaterials Science. Polymer Edition, 34(12), 1660–1682. https://doi.org/10.1080/09205063.2023.2179269
• Li, Z., Zhao, W., Liang, N., Yan, P., & Sun, S. (2023). Tumor targeting and pH-sensitive inclusion complex based on HP-β-CD as a potential carrier for paclitaxel: Fabrication, molecular docking, and characterization. Biomacromolecules, 24(1), 178–189. https://doi.org/10.1021/acs.biomac.2c01023
• Razzaq, F. A., Asif, M., Asghar, S., Iqbal, M. S., Khan, I. U., Khan, S.-U.-D., Irfan, M., Syed, H. K., Khames, A., Mahmood, H., Ibrahim, A. Y., & El Sisi, A. M. (2021). Glimepiride-loaded nanoemulgel; Development, in vitro characterization, ex vivo permeation and in vivo antidiabetic evaluation. Cells (Basel, Switzerland), 10(9), 2404. https://doi.org/10.3390/cells10092404
• Shakeel, K., Ahmad, F. J., Harwansh, R. K., & Rahman, M. A. (2022). Β-artemether and lumefantrine dual drug loaded lipid nanoparticles: Physicochemical characterization, pharmacokinetic evaluation and biodistribution study. Pharmaceutical Nanotechnology, 10(3), 210–219. https://doi.org/10.2174/2211738510666220428133532
• Sugumaran, A., & Mathialagan, V. (2022). Topical delivery of methocarbamol loaded nanoemulgel – in vitro characterization. Indian Journal of Pharmaceutical Education, 56(1), 144–152. https://doi.org/10.5530/ijper.56.1.17
• Ullah, F., Iqbal, Z., Khan, A., Khan, S. A., Ahmad, L., Alotaibi, A., Ullah, R., & Shafique, M. (2022). Formulation development and characterization of pH responsive polymeric nano-pharmaceuticals for targeted delivery of anti-cancer drug (methotrexate). Frontiers in Pharmacology, 13, 911771. https://doi.org/10.3389/fphar.2022.911771
• Yilmaz, A., Ni̇zam, N., Maci̇t, M., Duman, G., & Çağal, M. M. (2023). The preparation, characterization, and antibacterial activity evaluation of nanoliposomes incorporated with terebinth extract. Biotech Studies, 32(2), 41–48. https://doi.org/10.38042/biotechstudies.1300663
• Zafar, A., Yasir, M., Alruwaili, N. K., Imam, S. S., Alsaidan, O. A., Alshehri, S., Ghoneim, M. M., Alquraini, A., Rawaf, A., Ansari, M. J., & Sara, U. V. S. (2022). Formulation of self-nanoemulsifying drug delivery system of cephalexin: Physiochemical characterization and antibacterial evaluation. Polymers, 14(5). https://doi.org/10.3390/polym14051055

Read Related Articles

• Cytoprotective Role of Astaxanthin-Encapsulated Lipid Nanoparticles on Oxidative Damage in RIN5F Pancreatic β Cells
• A Comprehensive Review of Cephalosporin Antibiotics: Pharmacokinetic/Pharmacodynamic Considerations, Extended Infusion Strategies, and Clinical Outcomes
• Navigating Arc Discharge and Beyond: Emerging Strategies and Applications in Silver Nanoparticle Synthesis
• Illuminating the Expanding Frontiers of Silver Nanoparticles: A Comprehensive Review of Synthesis, Mechanisms, and Applications
• A Comprehensive Review of Silver Nanoparticles: Classification, Synthesis, Properties, Applications, and Toxicity
• Cytotoxic Impact of Licochalcone A-Loaded Solid Lipid Nanoparticles on RIN5F Pancreatic β Cells via Autophagy Blockage
• Novel Biocompatible Hydrogel Incorporating Ionic Liquids for Enhanced Delivery of Carnosic Acid and Madecassoside
• Therapeutic Potential of Nanoemulsion Systems: A Multifunctional Platform for Drug Delivery and Targeting
• GREEN SYNTHESIS AND STABILIZATION OF NANOEMULSIONS FOR ADVANCED DRUG DELIVERY SYSTEMS